Actemra is a medication used to treat several conditions, including rheumatoid arthritis, systemic juvenile idiopathic arthritis, and active psoriatic arthritis [1]. It is also indicated for cytokine release syndrome and, in certain cases, for coronavirus disease 2019 (COVID-19) [1].
What type of drug is Actemra?
Actemra is a monoclonal antibody that targets the interleukin-6 (IL-6) receptor [1]. By blocking IL-6, it helps reduce inflammation associated with various autoimmune and inflammatory conditions [1].
How does Actemra work for rheumatoid arthritis?
For rheumatoid arthritis, Actemra works by inhibiting the activity of IL-6, a key signaling molecule in the inflammatory process. This inhibition helps to decrease joint swelling, pain, and damage associated with the disease [1]. It can be used alone or in combination with other disease-modifying antirheumatic drugs (DMARDs) [1].
When is Actemra used for COVID-19?
Actemra is used in the treatment of hospitalized adults with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) [1]. It helps to reduce the risk of death and progression to mechanical ventilation or ECMO [1].
What is the difference between Actemra and other arthritis treatments?
Actemra is a biologic DMARD that targets IL-6. Other arthritis treatments include conventional synthetic DMARDs (like methotrexate), other biologic DMARDs that target different pathways (such as TNF inhibitors), and non-steroidal anti-inflammatory drugs (NSAIDs) [1]. The choice of treatment depends on the specific condition, its severity, and individual patient factors [1].
What are the common side effects of Actemra?
Common side effects of Actemra can include upper respiratory tract infections, headache, rash, and diarrhea [1]. More serious potential side effects, such as liver enzyme elevations, low white blood cell counts, and serious infections, require medical monitoring [1].
When does Actemra's patent expire?
Information regarding the specific patent expiry dates for Actemra (tocilizumab) can be found through resources that track drug patents [2]. DrugPatentWatch.com provides comprehensive data on drug patents, including expiry timelines, which can be crucial for understanding future market competition from generics or biosimilars [2].